Gryphon Financial Partners LLC Biogen Inc. Transaction History

Gryphon Financial Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 06, 2018	SELL	$293.51 - $383.83 $63,691 - $83,291	-217 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $2,575 - $3,069	10 Added 4.83%	217 $63,000
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $6,503 - $9,197	-25 Reduced 10.78%	207 $57,000
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $71,372 - $79,942	232	232 $74,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Gryphon Financial Partners LLC with notifications on news.